Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.

[1]  T. Kita,et al.  Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  B. Biccard,et al.  A meta‐analysis of the utility of pre‐operative brain natriuretic peptide in predicting early and intermediate‐term mortality and major adverse cardiac events in vascular surgical patients , 2008, Anaesthesia.

[3]  W. Berry,et al.  An estimation of the global volume of surgery: a modelling strategy based on available data , 2008, The Lancet.

[4]  M. Jeong,et al.  Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[5]  Jeroen J. Bax,et al.  Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. , 2008, The American journal of cardiology.

[6]  Jeroen J. Bax,et al.  Baseline natriuretic peptide levels in relation to myocardial ischemia, troponin T release and heart rate variability in patients undergoing major vascular surgery , 2007, Coronary artery disease.

[7]  G. Vanzetto,et al.  N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[8]  G. Hillis,et al.  The utility of B‐type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non‐cardiac surgery , 2007, Anaesthesia.

[9]  G. Hillis,et al.  Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. , 2007, British journal of anaesthesia.

[10]  C. Berry,et al.  B‐type natriuretic peptide predicts cardiac morbidity and mortality after major surgery , 2007, The British journal of surgery.

[11]  P. Rehak,et al.  N-Terminal Pro-brain Natriuretic Peptide Identifies Patients at High Risk for Adverse Cardiac Outcome after Vascular Surgery , 2007, Anesthesiology.

[12]  G. Veronesi,et al.  Increased Perioperative N-Terminal Pro-B-Type Natriuretic Peptide Levels Predict Atrial Fibrillation After Thoracic Surgery for Lung Cancer , 2007, Circulation.

[13]  Jeroen J. Bax,et al.  Plasma N-Terminal Pro-B-Type Natriuretic Peptide as a Long-Term Prognostic Marker After Major Vascular Surgery , 2007, Journal of Vascular Surgery.

[14]  Jeroen J. Bax,et al.  Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. , 2006, The American journal of cardiology.

[15]  J. Dernellis,et al.  Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients , 2006, Heart.

[16]  C. Berry,et al.  Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery , 2005, Heart.

[17]  Gordon H. Guyatt,et al.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk , 2005, Canadian Medical Association Journal.

[18]  H. Yeh,et al.  Preoperative plasma N‐terminal pro‐brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non‐cardiac surgery , 2005, The British journal of surgery.

[19]  L. Køber,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease , 2005 .

[20]  A. Ferreira,et al.  N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.

[21]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[22]  J. Rehfeld,et al.  Increased cardiac BNP expression associated with myocardial ischemia , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[24]  H. Ector,et al.  The value of dipyridamole thallium scintigraphy and dobutamine stress echocardiography as predictors of cardiac complications following reconstruction of the abdominal aorta. , 2000, International angiology : a journal of the International Union of Angiology.

[25]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[26]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .

[27]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[28]  G. Vanzetto,et al.  Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. , 1996, The American journal of cardiology.

[29]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.